We were delighted to catch up with Professor Njira Lugogo (University of Michigan, Ann Arbor, MI, USA) around her presentation ‘Asthma Management: New Insights’, which was presented at CHEST 2021, 17-20 October 2021.
Questions
- What has recent research taught us about the heterogeneity of asthma? (0:12)
- What are the most promising potential future biomarkers for asthma? (1:39)
- What has been the impact of biologic therapies on outcomes in severe asthma, and what have we learned about their optimal use? (3:28)
Disclosures: Njira Lugogo received consulting fees for advisory board participation from Amgen, AstraZeneca, Genentech, GSK, Novartis, Regeneron, Sanofi, and Teva; honoraria for non-speakers bureau presentations from GSK and Astra Zeneca; and travel support from Astra Zeneca; her institution received research support from Amgen, AstraZeneca, Avillion, Gossamer Bio, Genentech, GSK, Regeneron, Sanofi, and Teva.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.
Filmed as a highlight of CHEST 2021 (Virtual).
